Andrew D Fesnak, MD

faculty photo
Assistant Professor of Clinical Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
3 White Building
Hospital of the University of Pennsylvania
Philadephia, PA 19104
Office: 215-662-3325
Education:
BA (Molecular Biology)
Princeton University, 2005.
MD
University of Medicine and Dentistry of New Jersey - Robert Wood Johnson School of Medicine, 2011.
MS (Health Care Innovation)
University of Pennsylvania, 2019.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Ohayon, Y et al.: Robust automated cell counter and viability measurement for engineered T cell product release. Cytotherapy 20(5): S195, May 2018.

Fesnak A, Levine B: Good Manufacturing Practices Facilities for Cellular Therapy. Immunotherapy in Translational Cancer Research. Cooper LJN, Mittendorf EA, Moyes J, Prabhakaran S (eds.). John Wiley & Sons Inc. Page: 177, Feb 2018.

Fesnak AD, Hanley PJ, Levine BL: Considerations in T Cell Therapy Product Development for B cell leukemia and lymphoma immunotherapy. Curr Hematol Malig Rep Jul 2017.

Levine B, Fesnak A, Riviere I: Showcasing Clinical Development and Production of Cellular Therapies. Mol Ther 25(4): 827-828, April 2017.

Fesnak A, Suhoski Davis M, Levine B: Production of chimeric antigen receptor (CAR) T cells. Nature Protocols. Clyne M, Barnes K (eds.). Springer Nature, 12(4), April 2017.

Fesnak A, O'Doherty U: Clinical Development and Manufacture of Chimeric Antigen Receptor T cells and the Role of Leukapheresis. European Oncology and Hematology 13(1), 2017.

Davis, M. M., et al.: Predictors of Manufacturing (Mfg) Success for Chimeric Antigen Receptor (Car) T Cells in Non-Hodgkin Lymphoma. Cytotherapy 19(5): S79-S80, 2017.

Fesnak, A., Lin, C. Y., Siegel, D. L., Maus, M. V.: CAR-T Cell Therapies From the Transfusion Medicine Perspective. Transfusion Medicine Reviews 30(3): 139-145, 2016.

Fesnak A, Levine B: Immunotherapy with Autologous Cells. Reviews in Cell Biology and Molecular Medicine. Wiley-VCH Verlag GmbH & Co. KGaA, 2016.

Fesnak, A. D., June, C. H., Levine, B. L.: Engineered T cells: the promise and challenges of cancer immunotherapy. Nature Reviews Cancer 16(9): 566-581, 2016.

back to top
Last updated: 10/11/2018
The Trustees of the University of Pennsylvania